APO Research

APO RESEARCH · REPORT

EO Residual Testing

Selected research

Market Analysis & Forecast

Global EO Residual Testing Market Analysis and Forecast 2026-2032

Market perspective

The global EO Residual Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for EO Residual Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for EO Residual Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for EO Residual Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for EO Residual Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of EO Residual Testing include Eurofins Scientific, Nelson Labs, Steris, JordiLabs, LLC, TÜV SÜD, UFAG LABORATORIEN AG, Europejski Instytut Biomedyczny, SaniChem and Millstone Medical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for EO Residual Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of EO Residual Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for EO Residual Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the EO Residual Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global EO Residual Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for EO Residual Testing revenue, projected growth trends, production technology, application and end-user industry.

EO Residual Testing Segment by Company

Eurofins Scientific

Nelson Labs

Steris

JordiLabs, LLC

TÜV SÜD

UFAG LABORATORIEN AG

Europejski Instytut Biomedyczny

SaniChem

Millstone Medical

Medistri

Auriga Research

Pace Analytical

STEMart

MCI

EO Residual Testing Segment by Type

Brief Contact(up to 24 Hour)

Long Term Contact(more than 1 Days)

EO Residual Testing Segment by Application

Pharmaceuticals

Medical Devices

Food Products

Others

EO Residual Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EO Residual Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of EO Residual Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EO Residual Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of EO Residual Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of EO Residual Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, EO Residual Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global EO Residual Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Brief Contact(up to 24 Hour) Major Player Table 3. Long Term Contact(more than 1 Days) Major Player Table 4. Global EO Residual Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Pharmaceuticals Major Player Table 6. Medical Devices Major Player Table 7. Food Products Major Player Table 8. Others Major Player Table 9. EO Residual Testing Industry Trends Table 10. EO Residual Testing Industry Drivers Table 11. EO Residual Testing Industry Opportunities and Challenges Table 12. EO Residual Testing Industry Restraints Table 13. Global EO Residual Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global EO Residual Testing Market Size by Region (2021-2026) & (US$ Million) Table 15. Global EO Residual Testing Market Share by Region (2021-2026) Table 16. Global EO Residual Testing Market Size by Region (2027-2032) & (US$ Million) Table 17. Global EO Residual Testing Market Share by Region (2027-2032) Table 18. Global EO Residual Testing Revenue by Players (US$ Million) & (2021-2026) Table 19. Global EO Residual Testing Revenue Market Share by Players (2021-2026) Table 20. Global EO Residual Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global EO Residual Testing Key Players Headquarters & Area Served Table 22. Global EO Residual Testing Players, Product Type & Application Table 23. Global EO Residual Testing Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global EO Residual Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global EO Residual Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global EO Residual Testing Revenue by Type (2021-2026) & (US$ Million) Table 28. Global EO Residual Testing Revenue by Type (2027-2032) & (US$ Million) Table 29. Global EO Residual Testing Revenue Market Share by Type (2021-2026) Table 30. Global EO Residual Testing Revenue Market Share by Type (2027-2032) Table 31. Global EO Residual Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global EO Residual Testing Revenue by Application (2021-2026) & (US$ Million) Table 33. Global EO Residual Testing Revenue by Application (2027-2032) & (US$ Million) Table 34. Global EO Residual Testing Revenue Market Share by Application (2021-2026) Table 35. Global EO Residual Testing Revenue Market Share by Application (2027-2032) Table 36. Eurofins Scientific Company Information Table 37. Eurofins Scientific Business Overview Table 38. Eurofins Scientific EO Residual Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Eurofins Scientific EO Residual Testing Product Portfolio Table 40. Eurofins Scientific Recent Development Table 41. Nelson Labs Company Information Table 42. Nelson Labs Business Overview Table 43. Nelson Labs EO Residual Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Nelson Labs EO Residual Testing Product Portfolio Table 45. Nelson Labs Recent Development Table 46. Steris Company Information Table 47. Steris Business Overview Table 48. Steris EO Residual Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Steris EO Residual Testing Product Portfolio Table 50. Steris Recent Development Table 51. JordiLabs, LLC Company Information Table 52. JordiLabs, LLC Business Overview Table 53. JordiLabs, LLC EO Residual Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. JordiLabs, LLC EO Residual Testing Product Portfolio Table 55. JordiLabs, LLC Recent Development Table 56. TÜV SÜD Company Information Table 57. TÜV SÜD Business Overview Table 58. TÜV SÜD EO Residual Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. TÜV SÜD EO Residual Testing Product Portfolio Table 60. TÜV SÜD Recent Development Table 61. UFAG LABORATORIEN AG Company Information Table 62. UFAG LABORATORIEN AG Business Overview Table 63. UFAG LABORATORIEN AG EO Residual Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. UFAG LABORATORIEN AG EO Residual Testing Product Portfolio Table 65. UFAG LABORATORIEN AG Recent Development Table 66. Europejski Instytut Biomedyczny Company Information Table 67. Europejski Instytut Biomedyczny Business Overview Table 68. Europejski Instytut Biomedyczny EO Residual Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Europejski Instytut Biomedyczny EO Residual Testing Product Portfolio Table 70. Europejski Instytut Biomedyczny Recent Development Table 71. SaniChem Company Information Table 72. SaniChem Business Overview Table 73. SaniChem EO Residual Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. SaniChem EO Residual Testing Product Portfolio Table 75. SaniChem Recent Development Table 76. Millstone Medical Company Information Table 77. Millstone Medical Business Overview Table 78. Millstone Medical EO Residual Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Millstone Medical EO Residual Testing Product Portfolio Table 80. Millstone Medical Recent Development Table 81. Medistri Company Information Table 82. Medistri Business Overview Table 83. Medistri EO Residual Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Medistri EO Residual Testing Product Portfolio Table 85. Medistri Recent Development Table 86. Auriga Research Company Information Table 87. Auriga Research Business Overview Table 88. Auriga Research EO Residual Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Auriga Research EO Residual Testing Product Portfolio Table 90. Auriga Research Recent Development Table 91. Pace Analytical Company Information Table 92. Pace Analytical Business Overview Table 93. Pace Analytical EO Residual Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Pace Analytical EO Residual Testing Product Portfolio Table 95. Pace Analytical Recent Development Table 96. STEMart Company Information Table 97. STEMart Business Overview Table 98. STEMart EO Residual Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. STEMart EO Residual Testing Product Portfolio Table 100. STEMart Recent Development Table 101. MCI Company Information Table 102. MCI Business Overview Table 103. MCI EO Residual Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. MCI EO Residual Testing Product Portfolio Table 105. MCI Recent Development Table 106. North America EO Residual Testing Revenue by Type (2021-2026) & (US$ Million) Table 107. North America EO Residual Testing Revenue by Type (2027-2032) & (US$ Million) Table 108. North America EO Residual Testing Revenue by Application (2021-2026) & (US$ Million) Table 109. North America EO Residual Testing Revenue by Application (2027-2032) & (US$ Million) Table 110. North America EO Residual Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. North America EO Residual Testing Revenue by Country (2021-2026) & (US$ Million) Table 112. North America EO Residual Testing Revenue by Country (US$ Million) & (2027-2032) Table 113. Europe EO Residual Testing Revenue by Type (2021-2026) & (US$ Million) Table 114. Europe EO Residual Testing Revenue by Type (2027-2032) & (US$ Million) Table 115. Europe EO Residual Testing Revenue by Application (2021-2026) & (US$ Million) Table 116. Europe EO Residual Testing Revenue by Application (2027-2032) & (US$ Million) Table 117. Europe EO Residual Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Europe EO Residual Testing Revenue by Country (2021-2026) & (US$ Million) Table 119. Europe EO Residual Testing Revenue by Country (US$ Million) & (2027-2032) Table 120. China EO Residual Testing Revenue by Type (2021-2026) & (US$ Million) Table 121. China EO Residual Testing Revenue by Type (2027-2032) & (US$ Million) Table 122. China EO Residual Testing Revenue by Application (2021-2026) & (US$ Million) Table 123. China EO Residual Testing Revenue by Application (2027-2032) & (US$ Million) Table 124. Asia EO Residual Testing Revenue by Type (2021-2026) & (US$ Million) Table 125. Asia EO Residual Testing Revenue by Type (2027-2032) & (US$ Million) Table 126. Asia EO Residual Testing Revenue by Application (2021-2026) & (US$ Million) Table 127. Asia EO Residual Testing Revenue by Application (2027-2032) & (US$ Million) Table 128. Asia EO Residual Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Asia EO Residual Testing Revenue by Region (US$ Million) & (2021-2026) Table 130. Asia EO Residual Testing Revenue by Region (US$ Million) & (2027-2032) Table 131. SAMEA EO Residual Testing Revenue by Type (2021-2026) & (US$ Million) Table 132. SAMEA EO Residual Testing Revenue by Type (2027-2032) & (US$ Million) Table 133. SAMEA EO Residual Testing Revenue by Application (2021-2026) & (US$ Million) Table 134. SAMEA EO Residual Testing Revenue by Application (2027-2032) & (US$ Million) Table 135. SAMEA EO Residual Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. SAMEA EO Residual Testing Revenue by Country (2021-2026) & (US$ Million) Table 137. SAMEA EO Residual Testing Revenue by Country (US$ Million) & (2027-2032) Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. EO Residual Testing Image Figure 2. Global EO Residual Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global EO Residual Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Brief Contact(up to 24 Hour) Image Figure 5. Long Term Contact(more than 1 Days) Image Figure 6. Global EO Residual Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global EO Residual Testing Market Size Share 2021 VS 2025 VS 2032 Figure 8. Pharmaceuticals Image Figure 9. Medical Devices Image Figure 10. Food Products Image Figure 11. Others Image Figure 12. Global EO Residual Testing Market Size (US$ Million) & (2021-2032) Figure 13. Global EO Residual Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global EO Residual Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global EO Residual Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global EO Residual Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global EO Residual Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global EO Residual Testing Revenue Market Share by Type (2021-2032) Figure 20. Global EO Residual Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global EO Residual Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global EO Residual Testing Revenue Market Share by Application (2021-2032) Figure 23. North America EO Residual Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America EO Residual Testing Revenue Share by Type (2021-2032) Figure 25. North America EO Residual Testing Revenue Share by Application (2021-2032) Figure 26. North America EO Residual Testing Revenue Share by Country (2021-2032) Figure 27. United States EO Residual Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada EO Residual Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico EO Residual Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe EO Residual Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe EO Residual Testing Revenue Share by Type (2021-2032) Figure 32. Europe EO Residual Testing Revenue Share by Application (2021-2032) Figure 33. Europe EO Residual Testing Revenue Share by Country (2021-2032) Figure 34. Germany EO Residual Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France EO Residual Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. EO Residual Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy EO Residual Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain EO Residual Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia EO Residual Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands EO Residual Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries EO Residual Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China EO Residual Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China EO Residual Testing Revenue Share by Type (2021-2032) Figure 44. China EO Residual Testing Revenue Share by Application (2021-2032) Figure 45. Asia EO Residual Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia EO Residual Testing Revenue Share by Type (2021-2032) Figure 47. Asia EO Residual Testing Revenue Share by Application (2021-2032) Figure 48. Asia EO Residual Testing Revenue Share by Region (2021-2032) Figure 49. Japan EO Residual Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea EO Residual Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India EO Residual Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia EO Residual Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan EO Residual Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia EO Residual Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA EO Residual Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA EO Residual Testing Revenue Share by Type (2021-2032) Figure 57. SAMEA EO Residual Testing Revenue Share by Application (2021-2032) Figure 58. SAMEA EO Residual Testing Revenue Share by Country (2021-2032) Figure 59. Brazil EO Residual Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina EO Residual Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile EO Residual Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia EO Residual Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru EO Residual Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia EO Residual Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel EO Residual Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE EO Residual Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey EO Residual Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran EO Residual Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt EO Residual Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Brief Contact(up to 24 Hour)
  • Long Term Contact(more than 1 Days)
Applications
  • Pharmaceuticals
  • Medical Devices
  • Food Products
  • Others
Companies covered
  • Eurofins Scientific
  • Nelson Labs
  • Steris
  • JordiLabs, LLC
  • TÜV SÜD
  • UFAG LABORATORIEN AG
  • Europejski Instytut Biomedyczny
  • SaniChem
  • Millstone Medical
  • Medistri
  • Auriga Research
  • Pace Analytical
  • STEMart
  • MCI

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 EO Residual Testing Market by Type
  3. 1.2.1 Global EO Residual Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Brief Contact(up to 24 Hour)
  5. 1.2.3 Long Term Contact(more than 1 Days)
  6. 1.3 EO Residual Testing Market by Application
  7. 1.3.1 Global EO Residual Testing Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmaceuticals
  9. 1.3.3 Medical Devices
  10. 1.3.4 Food Products
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 EO Residual Testing Market Dynamics
  1. 2.1 EO Residual Testing Industry Trends
  2. 2.2 EO Residual Testing Industry Drivers
  3. 2.3 EO Residual Testing Industry Opportunities and Challenges
  4. 2.4 EO Residual Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global EO Residual Testing Market Perspective (2021-2032)
  2. 3.2 Global EO Residual Testing Growth Trends by Region
  3. 3.2.1 Global EO Residual Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global EO Residual Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global EO Residual Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global EO Residual Testing Revenue by Players
  2. 4.1.1 Global EO Residual Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global EO Residual Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global EO Residual Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global EO Residual Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global EO Residual Testing Key Players Headquarters & Area Served
  7. 4.4 Global EO Residual Testing Players, Product Type & Application
  8. 4.5 Global EO Residual Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global EO Residual Testing Market CR5 and HHI
  11. 4.6.3 2025 EO Residual Testing Tier 1, Tier 2, and Tier 3
5 EO Residual Testing Market Size by Type
  1. 5.1 Global EO Residual Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global EO Residual Testing Revenue by Type (2021-2032)
  3. 5.3 Global EO Residual Testing Revenue Market Share by Type (2021-2032)
6 EO Residual Testing Market Size by Application
  1. 6.1 Global EO Residual Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global EO Residual Testing Revenue by Application (2021-2032)
  3. 6.3 Global EO Residual Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Eurofins Scientific
  2. 7.1.1 Eurofins Scientific Company Information
  3. 7.1.2 Eurofins Scientific Business Overview
  4. 7.1.3 Eurofins Scientific EO Residual Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Eurofins Scientific EO Residual Testing Product Portfolio
  6. 7.1.5 Eurofins Scientific Recent Developments
  7. 7.2 Nelson Labs
  8. 7.2.1 Nelson Labs Company Information
  9. 7.2.2 Nelson Labs Business Overview
  10. 7.2.3 Nelson Labs EO Residual Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Nelson Labs EO Residual Testing Product Portfolio
  12. 7.2.5 Nelson Labs Recent Developments
  13. 7.3 Steris
  14. 7.3.1 Steris Company Information
  15. 7.3.2 Steris Business Overview
  16. 7.3.3 Steris EO Residual Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Steris EO Residual Testing Product Portfolio
  18. 7.3.5 Steris Recent Developments
  19. 7.4 JordiLabs, LLC
  20. 7.4.1 JordiLabs, LLC Company Information
  21. 7.4.2 JordiLabs, LLC Business Overview
  22. 7.4.3 JordiLabs, LLC EO Residual Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 JordiLabs, LLC EO Residual Testing Product Portfolio
  24. 7.4.5 JordiLabs, LLC Recent Developments
  25. 7.5 TÜV SÜD
  26. 7.5.1 TÜV SÜD Company Information
  27. 7.5.2 TÜV SÜD Business Overview
  28. 7.5.3 TÜV SÜD EO Residual Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 TÜV SÜD EO Residual Testing Product Portfolio
  30. 7.5.5 TÜV SÜD Recent Developments
  31. 7.6 UFAG LABORATORIEN AG
  32. 7.6.1 UFAG LABORATORIEN AG Company Information
  33. 7.6.2 UFAG LABORATORIEN AG Business Overview
  34. 7.6.3 UFAG LABORATORIEN AG EO Residual Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 UFAG LABORATORIEN AG EO Residual Testing Product Portfolio
  36. 7.6.5 UFAG LABORATORIEN AG Recent Developments
  37. 7.7 Europejski Instytut Biomedyczny
  38. 7.7.1 Europejski Instytut Biomedyczny Company Information
  39. 7.7.2 Europejski Instytut Biomedyczny Business Overview
  40. 7.7.3 Europejski Instytut Biomedyczny EO Residual Testing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Europejski Instytut Biomedyczny EO Residual Testing Product Portfolio
  42. 7.7.5 Europejski Instytut Biomedyczny Recent Developments
  43. 7.8 SaniChem
  44. 7.8.1 SaniChem Company Information
  45. 7.8.2 SaniChem Business Overview
  46. 7.8.3 SaniChem EO Residual Testing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 SaniChem EO Residual Testing Product Portfolio
  48. 7.8.5 SaniChem Recent Developments
  49. 7.9 Millstone Medical
  50. 7.9.1 Millstone Medical Company Information
  51. 7.9.2 Millstone Medical Business Overview
  52. 7.9.3 Millstone Medical EO Residual Testing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Millstone Medical EO Residual Testing Product Portfolio
  54. 7.9.5 Millstone Medical Recent Developments
  55. 7.10 Medistri
  56. 7.10.1 Medistri Company Information
  57. 7.10.2 Medistri Business Overview
  58. 7.10.3 Medistri EO Residual Testing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Medistri EO Residual Testing Product Portfolio
  60. 7.10.5 Medistri Recent Developments
  61. 7.11 Auriga Research
  62. 7.11.1 Auriga Research Company Information
  63. 7.11.2 Auriga Research Business Overview
  64. 7.11.3 Auriga Research EO Residual Testing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Auriga Research EO Residual Testing Product Portfolio
  66. 7.11.5 Auriga Research Recent Developments
  67. 7.12 Pace Analytical
  68. 7.12.1 Pace Analytical Company Information
  69. 7.12.2 Pace Analytical Business Overview
  70. 7.12.3 Pace Analytical EO Residual Testing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Pace Analytical EO Residual Testing Product Portfolio
  72. 7.12.5 Pace Analytical Recent Developments
  73. 7.13 STEMart
  74. 7.13.1 STEMart Company Information
  75. 7.13.2 STEMart Business Overview
  76. 7.13.3 STEMart EO Residual Testing Revenue and Gross Margin (2021-2026)
  77. 7.13.4 STEMart EO Residual Testing Product Portfolio
  78. 7.13.5 STEMart Recent Developments
  79. 7.14 MCI
  80. 7.14.1 MCI Company Information
  81. 7.14.2 MCI Business Overview
  82. 7.14.3 MCI EO Residual Testing Revenue and Gross Margin (2021-2026)
  83. 7.14.4 MCI EO Residual Testing Product Portfolio
  84. 7.14.5 MCI Recent Developments
8 North America
  1. 8.1 North America EO Residual Testing Revenue (2021-2032)
  2. 8.2 North America EO Residual Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America EO Residual Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America EO Residual Testing Revenue by Type (2027-2032)
  5. 8.3 North America EO Residual Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America EO Residual Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America EO Residual Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America EO Residual Testing Revenue by Application (2027-2032)
  9. 8.5 North America EO Residual Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America EO Residual Testing Revenue by Country
  11. 8.6.1 North America EO Residual Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America EO Residual Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America EO Residual Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe EO Residual Testing Revenue (2021-2032)
  2. 9.2 Europe EO Residual Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe EO Residual Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe EO Residual Testing Revenue by Type (2027-2032)
  5. 9.3 Europe EO Residual Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe EO Residual Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe EO Residual Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe EO Residual Testing Revenue by Application (2027-2032)
  9. 9.5 Europe EO Residual Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe EO Residual Testing Revenue by Country
  11. 9.6.1 Europe EO Residual Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe EO Residual Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe EO Residual Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China EO Residual Testing Revenue (2021-2032)
  2. 10.2 China EO Residual Testing Revenue by Type (2021-2032)
  3. 10.2.1 China EO Residual Testing Revenue by Type (2021-2026)
  4. 10.2.2 China EO Residual Testing Revenue by Type (2027-2032)
  5. 10.3 China EO Residual Testing Revenue Share by Type (2021-2032)
  6. 10.4 China EO Residual Testing Revenue by Application (2021-2032)
  7. 10.4.1 China EO Residual Testing Revenue by Application (2021-2026)
  8. 10.4.2 China EO Residual Testing Revenue by Application (2027-2032)
  9. 10.5 China EO Residual Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia EO Residual Testing Revenue (2021-2032)
  2. 11.2 Asia EO Residual Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia EO Residual Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia EO Residual Testing Revenue by Type (2027-2032)
  5. 11.3 Asia EO Residual Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia EO Residual Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia EO Residual Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia EO Residual Testing Revenue by Application (2027-2032)
  9. 11.5 Asia EO Residual Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia EO Residual Testing Revenue by Country
  11. 11.6.1 Asia EO Residual Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia EO Residual Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia EO Residual Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA EO Residual Testing Revenue (2021-2032)
  2. 12.2 SAMEA EO Residual Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA EO Residual Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA EO Residual Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA EO Residual Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA EO Residual Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA EO Residual Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA EO Residual Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA EO Residual Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA EO Residual Testing Revenue by Country
  11. 12.6.1 SAMEA EO Residual Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA EO Residual Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA EO Residual Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research